A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)

Birmingham

Huntsville

Paradise Valley

La Jolla

Los Angeles

Santa Monica

Torrance

Upland

Trumbull

Aventura

Jacksonville

Jupiter

Largo

Palm Harbor

Tamarac

Moline

Springfield

Cedar Rapids

Witchita

Louisville

Wheaton

Boston

Rochester

St Louis

Syracuse

Charlotte

Wilmington

Cincinnati

Mayfield

Duncansville

Pittsburgh

West Reading

Knoxville

Fort Worth

Houston

Lubbock

Arlington

Spokane

Brookfield

Racine

Adelaide

Cotton Tree

Melbourne

Graz

Lainz/Wien N/A

Vienna

Victoria

Winnipeg

St. John's

Kitchener

Newmarket

Ottawa

Toronto

Sainte-Foy

Claire

Helsinki

Hyvinkää

Jyvalskyla

Baden-Baden

Berlin

Cologne

Erlangen

Hamburg

Herne

München

Vogelsang-Gommern

Würzburg

Maastricht

Auckland

Rotorua

Timaru

Santander

Seville

Valencia

Leeds

London

Oxford